These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31314188)

  • 1. Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients.
    Kara AV; Yıldırım Y; Ozcicek F; Aldemir MN; Arslan Y; Bayan K; Çelen MK
    Acta Gastroenterol Belg; 2019; 82(2):273-277. PubMed ID: 31314188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
    Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Wang JH; Lu SN; Lee CM; Chang KC; Yen YH; Lin MT; Chou YP; Hu TH
    Clin Microbiol Infect; 2016 Jan; 22(1):95.e1-95.e7. PubMed ID: 26055419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.
    Tsai MC; Chen CH; Hung CH; Lee CM; Chiu KW; Wang JH; Lu SN; Tseng PL; Chang KC; Yen YH; Hu TH
    Clin Microbiol Infect; 2014 Feb; 20(2):O90-O100. PubMed ID: 23659493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Effects of Telbivudine Versus Entecavir on Renal Function in Patients With Chronic Hepatitis B Virus Receiving Glucocorticoids Therapy.
    Liu B; Shen B; Mei M; Li L; Wang X; Zhao H
    Ther Apher Dial; 2020 Feb; 24(1):56-63. PubMed ID: 31090170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir.
    Viganò M; Loglio A; Labanca S; Zaltron S; Castelli F; Andreone P; Messina V; Ganga R; Coppola N; Marrone A; Russello M; Marzano A; Tucci A; Taliani G; Fasano M; Fagiuoli S; Villa E; Bronte F; Santantonio T; Brancaccio G; Occhipinti V; Facchetti F; Grossi G; Rumi M; Lampertico P
    Liver Int; 2019 Mar; 39(3):484-493. PubMed ID: 30525275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of monotherapy with telbivudine or entecavir on renal function in patients with chronic hepatitis B].
    Li W; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jun; 23(6):407-11. PubMed ID: 26236924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B.
    Lee S; Park JY; Song K; Kim DY; Kim BK; Kim SU; Ku HJ; Han KH; Ahn SH
    Gut Liver; 2015 Nov; 9(6):776-83. PubMed ID: 25963085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in serum β2-microglobulin, retinol-binding protein, and cystatin C and their value in identifying early renal dysfunction in patients with chronic hepatitis B undergoing tenofovir or entecavir monotherapy: a comparative analysis].
    He J; Ning HB; Zeng YL; Li W; Li K; Shang J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):643-646. PubMed ID: 27788718
    [No Abstract]   [Full Text] [Related]  

  • 9. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.
    Gish RG; Clark MD; Kane SD; Shaw RE; Mangahas MF; Baqai S
    Clin Gastroenterol Hepatol; 2012 Aug; 10(8):941-6; quiz e68. PubMed ID: 22507876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nucleos(t)ide analogue combination therapy on the estimated glomerular filtration rate in patients with chronic hepatitis B.
    Qi X; Wang J; Chen L; Huang Y; Qin Y; Mao R; Zhang J
    Medicine (Baltimore); 2015 Apr; 94(15):e646. PubMed ID: 25881837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis.
    Wu X; Cai S; Li Z; Zheng C; Xue X; Zeng J; Peng J
    Virol J; 2016 Apr; 13():64. PubMed ID: 27062520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study.
    Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Chang KC; Yen YH; Lin MT; Hu TH
    PLoS One; 2016; 11(3):e0149761. PubMed ID: 26964034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy.
    Law ST; Lee MK; Lee AS; Tung Y; Li KK
    J Dig Dis; 2016 May; 17(5):325-33. PubMed ID: 27085094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.
    Mallet V; Schwarzinger M; Vallet-Pichard A; Fontaine H; Corouge M; Sogni P; Pol S
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1181-8.e1. PubMed ID: 25460550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis.
    Lee HY; Oh H; Park CH; Yeo YH; Nguyen MH; Jun DW
    World J Gastroenterol; 2019 Jun; 25(23):2961-2972. PubMed ID: 31249453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir.
    Trinh S; Le AK; Chang ET; Hoang J; Jeong D; Chung M; Lee MH; Wang U; Henry L; Cheung R; Nguyen MH
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):948-956.e1. PubMed ID: 30130625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients.
    Lin YS; Shih SC; Wang HY; Lin CC; Chang CW; Chen MJ
    BMC Gastroenterol; 2017 Jan; 17(1):22. PubMed ID: 28137301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased eGFR with telbivudine in combination therapy of chronic hepatitis B infection.
    Amarapurkar DN; Patel N
    Indian J Gastroenterol; 2014 Jan; 33(1):89-91. PubMed ID: 23512213
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive patients: a prospective cohort study in China.
    Zhang Y; Hu P; Qi X; Ren H; Mao RC; Zhang JM
    Clin Microbiol Infect; 2016 Mar; 22(3):287.e1-9. PubMed ID: 26548508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg-positive cancer patients undergoing chemotherapy.
    Lee IC; Chao Y; Li CP; Su CW; Lan KH; Lin HC; Hou MC; Huang YH
    J Viral Hepat; 2018 Dec; 25(12):1599-1607. PubMed ID: 30125436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.